Evidence map›Paper›PMID 42356023›Full record

ArticleMedicina (Kaunas, Lithuania)2026

Clinicopathological Characteristics and Prognostic Impact of KRAS Mutations in Non-Small Cell Lung Cancer.

Tayyip İlker Aydın, Gökhan Öztürk, Aysun Fatma Akkuş, Ebru Taştekin, Sernaz Topaloğlu, Bülent Erdoğan, Ahmet Küçükarda, Muhammet Bekir Hacıoğlu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tayyip İlker AydınDepartment of Medical Oncology, Trakya University Faculty of Medicine, 22030 Edirne, Türkiye.ORCID 0000-0003-0064-954X
Gökhan ÖztürkDepartment of Medical Oncology, Trakya University Faculty of Medicine, 22030 Edirne, Türkiye.
Aysun Fatma AkkuşDepartment of Medical Oncology, Trakya University Faculty of Medicine, 22030 Edirne, Türkiye.ORCID 0000-0003-3922-3845
Ebru TaştekinDepartment of Pathology, Trakya University Faculty of Medicine, 22030 Edirne, Türkiye.
Sernaz TopaloğluDepartment of Medical Oncology, Trakya University Faculty of Medicine, 22030 Edirne, Türkiye.ORCID 0000-0001-5387-8309
Bülent ErdoğanDepartment of Medical Oncology, Trakya University Faculty of Medicine, 22030 Edirne, Türkiye.
Ahmet KüçükardaDepartment of Medical Oncology, Trakya University Faculty of Medicine, 22030 Edirne, Türkiye.ORCID 0000-0001-7399-2360
Muhammet Bekir HacıoğluDepartment of Medical Oncology, Trakya University Faculty of Medicine, 22030 Edirne, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsMutationProto-Oncogene Proteins p21(ras)AdultAgedAged, 80 and overB7-H1 AntigenFemaleHumansKaplan-Meier EstimateMaleMiddle AgedPrognosisProportional Hazards ModelsRetrospective StudiesB7-H1 AntigenKRAS protein, humanProto-Oncogene Proteins p21(ras)KRAS mutationnon-small cell lung cancerprognosisprogrammed cell death ligand 1 protein (PD-L1)

Identifiers

PMID42356023
PMCPMC13304285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.